86 related articles for article (PubMed ID: 21332425)
1. Experimental autoimmune thyroiditis in human parvovirus B19 transgenic mice.
Mori K; Yoshida K; Ishii K; Morohoshi K; Nakagawa Y; Hoshikawa S; Ozaki H; Takahashi Y; Ito S
Autoimmunity; 2011 Sep; 44(6):483-9. PubMed ID: 21332425
[TBL] [Abstract][Full Text] [Related]
2. Intrathyroidal persistence of human parvovirus B19 DNA in a patient with Hashimoto's thyroiditis.
Mori K; Munakata Y; Saito T; Tani J; Nakagawa Y; Hoshikawa S; Ozaki H; Ito S; Yoshida K
J Infect; 2007 Aug; 55(2):e29-31. PubMed ID: 17582502
[TBL] [Abstract][Full Text] [Related]
3. Association of parvovirus B19 infection and Hashimoto's thyroiditis in children.
Lehmann HW; Lutterbüse N; Plentz A; Akkurt I; Albers N; Hauffa BP; Hiort O; Schoenau E; Modrow S
Viral Immunol; 2008 Sep; 21(3):379-83. PubMed ID: 18788945
[TBL] [Abstract][Full Text] [Related]
4. Human parvovirus B19 transgenic mice become susceptible to polyarthritis.
Takasawa N; Munakata Y; Ishii KK; Takahashi Y; Takahashi M; Fu Y; Ishii T; Fujii H; Saito T; Takano H; Noda T; Suzuki M; Nose M; Zolla-Patzner S; Sasaki T
J Immunol; 2004 Oct; 173(7):4675-83. PubMed ID: 15383603
[TBL] [Abstract][Full Text] [Related]
5. The sphingosine 1-phosphate receptor modulator FTY720 prevents iodide-induced autoimmune thyroiditis in non-obese diabetic mice.
Morohoshi K; Osone M; Yoshida K; Nakagawa Y; Hoshikawa S; Ozaki H; Takahashi Y; Ito S; Mori K
Autoimmunity; 2011 Sep; 44(6):490-5. PubMed ID: 21457062
[TBL] [Abstract][Full Text] [Related]
6. Viral infection and innate pattern recognition receptors in induction of Hashimoto's thyroiditis.
Morohoshi K; Takahashi Y; Mori K
Discov Med; 2011 Dec; 12(67):505-11. PubMed ID: 22204767
[TBL] [Abstract][Full Text] [Related]
7. T lymphocyte line specific for thyroglobulin produces or vaccinates against autoimmune thyroiditis in mice.
Maron R; Zerubavel R; Friedman A; Cohen IR
J Immunol; 1983 Nov; 131(5):2316-22. PubMed ID: 6195260
[TBL] [Abstract][Full Text] [Related]
8. Parvovirus B19 nonstructural (NS1) protein as a transactivator of interleukin-6 synthesis: common pathway in inflammatory sequelae of human parvovirus infections?
Mitchell LA
J Med Virol; 2002 Jun; 67(2):267-74. PubMed ID: 11992589
[TBL] [Abstract][Full Text] [Related]
9. Sustained CD8+ T-cell responses induced after acute parvovirus B19 infection in humans.
Norbeck O; Isa A; Pöhlmann C; Broliden K; Kasprowicz V; Bowness P; Klenerman P; Tolfvenstam T
J Virol; 2005 Sep; 79(18):12117-21. PubMed ID: 16140790
[TBL] [Abstract][Full Text] [Related]
10. Characterization of a novel H2A(-)E+ transgenic model susceptible to heterologous but not self thyroglobulin in autoimmune thyroiditis: thyroiditis transfer with Vbeta8+ T cells.
Yan Y; Panos JC; McCormick DJ; Wan Q; Giraldo AA; Brusic V; David CS; Kong YC
Cell Immunol; 2001 Aug; 212(1):63-70. PubMed ID: 11716530
[TBL] [Abstract][Full Text] [Related]
11. Parvovirus B19 infection associated with Hashimoto's thyroiditis in adults.
Wang J; Zhang W; Liu H; Wang D; Wang W; Li Y; Wang Z; Wang L; Zhang W; Huang G
J Infect; 2010 May; 60(5):360-70. PubMed ID: 20153771
[TBL] [Abstract][Full Text] [Related]
12. Experimental autoimmune thyroiditis in nonobese diabetic mice lacking interferon regulatory factor-1.
Jin Z; Mori K; Fujimori K; Hoshikawa S; Tani J; Satoh J; Ito S; Satomi S; Yoshida K
Clin Immunol; 2004 Nov; 113(2):187-92. PubMed ID: 15451476
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of antibodies to human parvovirus B19 nonstructural protein in persons with various clinical outcomes following B19 infection.
Jones LP; Erdman DD; Anderson LJ
J Infect Dis; 1999 Aug; 180(2):500-4. PubMed ID: 10395869
[TBL] [Abstract][Full Text] [Related]
14. Effects of interleukin-6 blockade on the development of autoimmune thyroiditis in nonobese diabetic mice.
Mori K; Yoshida K; Mihara M; Ohsugi Y; Nakagawa Y; Hoshikawa S; Ozaki H; Ito S
Autoimmunity; 2009 Mar; 42(3):228-34. PubMed ID: 19301205
[TBL] [Abstract][Full Text] [Related]
15. Anti-human parvovirus B19 nonstructural protein antibodies in patients with rheumatoid arthritis.
Tzang BS; Tsai CC; Tsay GJ; Wang M; Sun YS; Hsu TC
Clin Chim Acta; 2009 Jul; 405(1-2):76-82. PubMed ID: 19362081
[TBL] [Abstract][Full Text] [Related]
16. CD4(+) T-cell responses against the VP1-unique region in individuals with recent and persistent parvovirus B19 infection.
Lindner J; Barabas S; Saar K; Altmann D; Pfister A; Fleck M; Deml L; Modrow S
J Vet Med B Infect Dis Vet Public Health; 2005; 52(7-8):356-61. PubMed ID: 16316401
[TBL] [Abstract][Full Text] [Related]
17. Antiphospholipid antibodies in pediatric and adult patients with rheumatic disease are associated with parvovirus B19 infection.
Von Landenberg P; Lehmann HW; Knöll A; Dorsch S; Modrow S
Arthritis Rheum; 2003 Jul; 48(7):1939-47. PubMed ID: 12847688
[TBL] [Abstract][Full Text] [Related]
18. Unscrambling the role of human parvovirus B19 signaling in systemic autoimmunity.
Tsay GJ; Zouali M
Biochem Pharmacol; 2006 Nov; 72(11):1453-9. PubMed ID: 16764828
[TBL] [Abstract][Full Text] [Related]
19. Bone marrow-derived cells are responsible for the development of autoimmune arthritis in human T cell leukemia virus type I-transgenic mice and those of normal mice can suppress the disease.
Saijo S; Kotani M; Habu K; Ishitsuka C; Yamamoto H; Sekiguchi T; Iwakura Y
J Immunol; 1999 Nov; 163(10):5700-7. PubMed ID: 10553101
[TBL] [Abstract][Full Text] [Related]
20. Characterization of a thyroiditis-inducing thyroglobulin-specific T-cell clone restricted by the H-2 molecule of a low responder mouse strain.
Hiyama Y; Kohno Y; Hoshioka A; Shimojo N; Tarutani O; Yokochi T; Maruyama N; Niimi H
Immunology; 1993 Nov; 80(3):488-92. PubMed ID: 8288321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
